Yeasen

Yisheng Biotechnology (Shanghai) Co., Ltd. (Yeasen Biotechnology (Shanghai) Co., Ltd.) is a high-tech enterprise driven by protein engineering and enzyme evolution technologies, focusing on core raw materials upstream of the life science industry chain. It engages in the research, development, production, and sales of biological reagents across three major categories: molecular, protein, and cell. By integrating the technical development pathways for molecular enzymes, proteins, antibodies, nucleic acids, and cells, it has become one of the few high-tech enterprises in China that covers all three categories of biological reagents while possessing both core technology self-research and large-scale production capabilities. Leveraging its technological advantages in protein engineering and enzyme evolution, as well as extensive experience accumulated over years in the biological reagent industry, the company has built a product pipeline with excellent quality, comprehensive types, and rich varieties. Since its establishment, the company has developed, produced, and sold thousands of biological reagents, covering molecular, protein, and cell categories, meeting customers' integrated procurement needs for various types of biological reagents. The company’s core products include qPCR series, NGS series, reverse transcription series, nucleic acid extraction and purification series, PCR series, molecular cloning series, in vitro transcription series, antibodies, protein purification series, protein analysis series, recombinant proteins, cell analysis series, cell culture series, cell transfection series, and reporter gene detection series. These biological reagents are widely used in life science research, diagnostic testing, and biopharmaceutical fields.